Healthcare
Belhaven Biopharma
View On Demand
Belhaven’s needle-free delivery system solves every problem associated with EpiPens, including cost.
Menu
Belhaven’s needle-free delivery system solves every problem associated with EpiPens, including cost.
Kineta has developed a new monoclonal antibody designed to reverse immunosuppression and stimulate T Cells.
QSAM has refined an FDA-approved treatment creating a heat seeking missile that has the potential to cure metastatic bone cancer
Gain Therapeutics has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research
Silence Therapeutics is developing a targeted treatment for the 132 million people at risk of heart disease thanks to high Lp(a) levels
bit.bio is unlocking the therapeutic potential of human cells based on a new paradigm – cell reprogramming
Lumeda is a clinical-stage medical technology company focused on improving treatment outcomes for patients with difficult-to-treat cancers.
Changing the lives of people who suffer from the jarring pain and loss of feeling caused by neuropathy
Join our panel discussion to learn more about DiscGenic’s unique technology and their ability to change lives
Creating a world where people can be physically and mentally healthy for their entire first century of life
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office